Genencell Co., Ltd.
PrivateLast Round
Convertible Debt
Oct 20, 2021
Total Funding Raised
$4.23M
Company Overview
Genencell Co., Ltd. is a biotechnology company that researches and develops medicines based on natural materials, health functional foods, and functional cosmetics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genencell Co., Ltd. Comparables
Compare Genencell Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MThera Pharma | 74% | |
| Bichedam Co., Ltd. | 67% | |
| Mediforum Co., Ltd | 66% | |
Genencell Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Oct 20, 2021 | ||||
| VC Round | Feb 3, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 20, 2021
$4.23M round led by Sejong Medical Co., Ltd.
- Feb 3, 2021
$2.7M round led by KOREA PHARMA Co., Ltd.
Genencell Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genencell Co., Ltd.'s valuation, stock price, and market status.